This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 December 2015.
All research outputs
#12,345,312
of 34,365,356 outputs
Outputs from CNS & Neurological Disorders - Drug Targets
#586
of 1,099 outputs
Outputs of similar age
#125,021
of 373,079 outputs
Outputs of similar age from CNS & Neurological Disorders - Drug Targets
#36
of 72 outputs
Altmetric has tracked 34,365,356 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,099 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 373,079 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
